BACKGROUND: Our goal was to investigate the correlation between the dysregulation of transforming growth factor-β1 (TGF-β1) and cystic medial degeneration in the aortic aneurysmal tissues of in Marfan syndrome (MFS) patients. Although aortic aneurysm in animal models of MFS is related to the dysregulation of TGF-β, it has yet to be determined whether TGF-β dysregulation correlates with pathogenic aneurysmal characteristics in MFS patients. METHODS AND RESULTS: Compared with aortic tissue from normal individuals, the medial layers of aortic tissue from MFS patients exhibited profound cystic medial degeneration and cellular apoptosis. These histopathologic changes positively correlated with the extent of TGF-β1 signaling activation (Smad2 phosphorylation) in aneurysmal aortic tissue. In addition, the level of TGF-β1 expression in peripheral blood and aneurysmal aortic tissues was significantly elevated in MFS patients. A significant positive correlation was observed between the plasma level of active TGF-β1 in MFS patients and the severity of cystic medial degeneration and Smad2 phosphorylation in aneurysmal aortic medial layers. CONCLUSIONS: We found a strong association between the dysregulation of TGF-β1 and aortic pathogenesis in human MFS patients. This suggests that the plasma concentration of TGF-β1 in MFS patients might be a useful biomarker of the progression of aortic aneurysms.
BACKGROUND: Our goal was to investigate the correlation between the dysregulation of transforming growth factor-β1 (TGF-β1) and cystic medial degeneration in the aortic aneurysmal tissues of in Marfan syndrome (MFS) patients. Although aortic aneurysm in animal models of MFS is related to the dysregulation of TGF-β, it has yet to be determined whether TGF-β dysregulation correlates with pathogenic aneurysmal characteristics in MFSpatients. METHODS AND RESULTS: Compared with aortic tissue from normal individuals, the medial layers of aortic tissue from MFSpatients exhibited profound cystic medial degeneration and cellular apoptosis. These histopathologic changes positively correlated with the extent of TGF-β1 signaling activation (Smad2 phosphorylation) in aneurysmal aortic tissue. In addition, the level of TGF-β1 expression in peripheral blood and aneurysmal aortic tissues was significantly elevated in MFSpatients. A significant positive correlation was observed between the plasma level of active TGF-β1 in MFSpatients and the severity of cystic medial degeneration and Smad2 phosphorylation in aneurysmal aortic medial layers. CONCLUSIONS: We found a strong association between the dysregulation of TGF-β1 and aortic pathogenesis in humanMFSpatients. This suggests that the plasma concentration of TGF-β1 in MFSpatients might be a useful biomarker of the progression of aortic aneurysms.
Authors: John Kuchtey; Jessica Kunkel; L Goodwin Burgess; Megan B Parks; Milam A Brantley; Rachel W Kuchtey Journal: Invest Ophthalmol Vis Sci Date: 2014-07-24 Impact factor: 4.799
Authors: Veronika C Stark; Michael Huemmer; Jakob Olfe; Goetz C Mueller; Rainer Kozlik-Feldmann; Thomas S Mir Journal: Pediatr Cardiol Date: 2018-04-25 Impact factor: 1.655
Authors: Jillian G Buchan; David M Alvarado; Gabe E Haller; Carlos Cruchaga; Matthew B Harms; Tianxiao Zhang; Marcia C Willing; Dorothy K Grange; Alan C Braverman; Nancy H Miller; Jose A Morcuende; Nelson Leung-Sang Tang; Tsz-Ping Lam; Bobby Kin-Wah Ng; Jack Chun-Yiu Cheng; Matthew B Dobbs; Christina A Gurnett Journal: Hum Mol Genet Date: 2014-05-15 Impact factor: 6.150
Authors: Zoltán Szabolcs; Kálmán Benke; Roland Stengl; Bence Ágg; Miklós Pólos; Gábor Mátyás; Gábor Szabó; Béla Merkely; Tamás Radovits Journal: Orphanet J Rare Dis Date: 2021-05-31 Impact factor: 4.123
Authors: Romy Franken; Stijntje Hibender; Alexander W den Hartog; Teodora Radonic; Carlie J M de Vries; Aeilko H Zwinderman; Maarten Groenink; Barbara J M Mulder; Vivian de Waard Journal: PLoS One Date: 2014-09-19 Impact factor: 3.240